Page last updated: 2024-08-24

milnacipran and hydromorphone

milnacipran has been researched along with hydromorphone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Burns, J; Comstock, K; Connolly, S; Gerson, T; Harden, RN; Khazey, K; Kirsling, A; Saracoglu, M1

Reviews

1 review(s) available for milnacipran and hydromorphone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for milnacipran and hydromorphone

ArticleYear
"Managing" the Placebo Effect: The Single-Blind Placebo Lead-in Response in Two Pain Models.
    Pain medicine (Malden, Mass.), 2016, Volume: 17, Issue:12

    Topics: Adult; Aged; Analgesics; Chronic Pain; Cyclopropanes; Double-Blind Method; Female; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Milnacipran; Osteoarthritis, Knee; Pain Measurement; Pilot Projects; Placebo Effect; Research Design; Single-Blind Method

2016

Other Studies

2 other study(ies) available for milnacipran and hydromorphone

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010